GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LBT Innovations Ltd (ASX:LBT) » Definitions » Debt-to-Revenue

LBT Innovations (ASX:LBT) Debt-to-Revenue : 1.09 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is LBT Innovations Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

LBT Innovations's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.21 Mil. LBT Innovations's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$1.34 Mil. LBT Innovations's annualized Revenue for the quarter that ended in Dec. 2023 was A$1.42 Mil. LBT Innovations's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 1.09.


LBT Innovations Debt-to-Revenue Historical Data

The historical data trend for LBT Innovations's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LBT Innovations Debt-to-Revenue Chart

LBT Innovations Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 3.33 4.33 2.02 1.59

LBT Innovations Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.13 1.27 1.01 1.33 1.09

Competitive Comparison of LBT Innovations's Debt-to-Revenue

For the Medical Devices subindustry, LBT Innovations's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LBT Innovations's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LBT Innovations's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where LBT Innovations's Debt-to-Revenue falls into.



LBT Innovations Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

LBT Innovations's Debt-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.194 + 2.193) / 2.132
=1.59

LBT Innovations's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.212 + 1.337) / 1.422
=1.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.


LBT Innovations Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of LBT Innovations's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LBT Innovations (ASX:LBT) Business Description

Traded in Other Exchanges
N/A
Address
16 Anster Street, Adelaide, SA, AUS, 5000
LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.

LBT Innovations (ASX:LBT) Headlines

No Headlines